Skip to content

Clinical trials

Phase 2 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Clear all

444 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20012
20027
200312
200416
200512
200619
200720
200812
200914
201018
201116
201217
201311
20149
201519
201629
201720
201824
201918
202019
202123
202217
202316
202415
202517
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed279
Unknown status50
Terminated35
Recruiting29
Active, not recruiting18
Withdrawn16
Not yet recruiting15
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)17
Institute for Neurodegenerative Disorders9
Chang Gung Memorial Hospital7
Eisai Inc.7
Biogen6
Kyowa Kirin Co., Ltd.6
Novartis5
Novartis Pharmaceuticals5
Oregon Health and Science University5
University College, London5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease444
Dyskinesias37
Movement Disorders25
Neurodegenerative Diseases14
Parkinsonian Disorders13
Central Nervous System Diseases10
Cognitive Dysfunction10
Tremor9
Anxiety Disorders7
Brain Diseases7

Trials

Showing 76 to 100 of 444. Each trial links to its page on Pharma Observatory.

344 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.